Hicham El Masry, MD | |
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
(480) 301-8000 | |
Not Available |
Full Name | Hicham El Masry |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 21 Years |
Location | 13400 E Shea Blvd, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205097110 | NPI | - | NPPES |
000000694490 | Other | IN | ANTHEM BCBS |
P00945280 | Other | IN | RAILROAD MEDICARE (SVMG) |
106658 | Medicaid | AZ | |
201007910 | Medicaid | IN |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Hospital | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.
Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).
In a bid to fight obesity, public-health researchers have been trying for decades to find a way to convince teenagers to skip junk food and eat healthily, to little avail.
› Verified 5 days ago
Entity Name | Mayo Clinic Arizona |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.
Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).
In a bid to fight obesity, public-health researchers have been trying for decades to find a way to convince teenagers to skip junk food and eat healthily, to little avail.
› Verified 5 days ago
Entity Name | Tri-city Cardiology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144288416 PECOS PAC ID: 2062303076 Enrollment ID: O20040322000116 |
News Archive
A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.
Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).
In a bid to fight obesity, public-health researchers have been trying for decades to find a way to convince teenagers to skip junk food and eat healthily, to little avail.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Hicham El Masry, MD 6402 E Superstition Springs Blvd Ste 224, Mesa, AZ 85206-4394 Ph: (480) 865-6100 | Hicham El Masry, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 |
News Archive
A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.
Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).
In a bid to fight obesity, public-health researchers have been trying for decades to find a way to convince teenagers to skip junk food and eat healthily, to little avail.
› Verified 5 days ago
Russell S Ruzich, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Dr. Paul Joseph Schenk, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11230 E Beck Ln, Scottsdale, AZ 85255 Phone: 480-502-9457 | |
Dr. Musab Sultan Hommos, M.B., B.S. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Soyoung Park, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10460 N 92nd St Ste 300, Scottsdale, AZ 85258 Phone: 480-323-1573 Fax: 480-323-1375 | |
Dr. Michael Edward Killian, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Mayo Clinic 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 085-120-6856 | |
Hesham Mubarak Ibrahim Moh Abdalla, M.B.B.S. Internal Medicine Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Kianoush Cheybani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9590 E Ironwood Square Dr, Ste 125, Scottsdale, AZ 85258 Phone: 480-455-3000 Fax: 866-819-6115 |